Advertisement

Topics

PierianDx Forms Strategic Partnership with Leading Research and Technical Services Organization RTI International

10:00 EDT 17 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
PierianDx, the leading genomics technology company that enables precision medicine, announced today a strategic partnership with RTI International to help solve the problem of translating complex genomic data into actionable cl...

Other Sources for this Article

PierianDx
Brad Herrick, 314-238-4476
brad.herrick@pieriandx.com

NEXT ARTICLE

More From BioPortfolio on "PierianDx Forms Strategic Partnership with Leading Research and Technical Services Organization RTI International"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...